logo/base Created with Sketch.

FibroScan HANDY®

The portable non-invasive solution for liver disease management, ideal for or primary care center screening & multi-site configuration.

Powered by LSM by VCTE™ and CAP™ for liver fibrosis and liver steatosis assessment.

wave

FibroScan HANDY® is designed for multi-center sharing and remote liver patient management.

Ergonomic design

LSM by VCTE™ is unique, patented and validated for liver fibrosis assessment. It is the standard for non-invasive evaluation of liver stiffness with 2,250 international peer-reviewed publications.1

CAP™ is unique patented and validated for liver steatosis assessment2,3 with 330 international peer-reviewed publications. 

 

What our users say

quote

FibroScan® is the most effective and best screening test for the diagnosis of chronic liver disease.

Nezam Afdhal | M.D. and Associate Professor of Medicine at Beth Israel Deaconess Medical Center – United States of America

chevron chevron

Products in the FibroScan® range are Class IIa medical devices as defined by Directive 93/42/EEC (EC 0459). These devices are designed for use in a medical practice in order to measure liver stiffness and ultrasound attenuation in patients with liver disease. Examinations with FibroScan® device shall be performed by an operator who has been certified by the manufacturer or its approved local representative. Operators are expressly recommended to carefully read the instructions given in the user manual and on the labelling of these products. Check cost defrayal conditions with paying bodies.

References are available in our bibliography.